investors intelligence
Generating first rate investment advice since 1947
Sample Research


ETF Global Opportunities
Weekly analysis on US stocks, sectors, commodities and global indices.
1 October 2014

Market Overview

Our short-term-composite is now deeply oversold. It may weaken slightly more, down to the August low at 4%, but it is unlikely to remain at these levels for much longer. Therefore a snap-back by the equity ETFs is anticipated soon. Once this indicator reverses back up it would be the signal to reduce shorts and add longs in reassertion candidates. Limited action this week as we watch developments. One new defensive buy and one new short in a weak emerging market currency.



This Week's Trades

  • DJ Select Dividend Index (DVY) - buying, stoploss at $71.90
  • Brazilian Real (BZF) - shorting, stoploss at $16.33

Note - Trades will be executed on today's close.

Other ETF Highlights


US Equity Indices

  • see trades

US Sector Indices

  • Consumer Staples (XLP) - buy reiterated
  • Health Care (XLV) - buy reiterated
  • Pharmaceuticals Index (IHE) - buy reiterated
  • Materials (XLB) - watch to buy above $50

Other Developed Indices

  • Hong Kong (EWH) - watch to cover shorts

Emerging Indices

  • Brazil Index (EWZ) - sell
  • China 25 Index (FXI) - sell
  • Emerging Market (EEM) - sell


  • see trades


  • US 20+ years (TLT) - buy



US Equity Indices

The DJ Select Dividend Index (DVY) has corrected down to likely support from the 200-day exponential moving average. Momentum, the 14-day RSI, is just above oversold. The uptrend is well positioned to reassert from here.

We shall buy the DVY today. The stoploss will be at $71.90.




US Sector Indices


We reiterate our buy advice in the Consumer Staples (XLP) ETF. The chart shows support from the 50-day exponential moving average being found and momentum is down to neutral. An upside reassertion looks imminent.



The Health Care (XLV) fund is an area we have bought and sold quite a few times given its reliable outperformance. We are currently long. The price has consolidated for the past two weeks, allowing the 14-day RSI to unwind to neutral. A reassertion looks at hand.



We also reiterate our buy advice for the Pharmaceuticals Index (IHE). The P&F price and relative charts both hold their uptrends with upside movement last month. New highs expected during October.



The Materials (XLB) fund is putting pressure on its 50-day exponential moving average. The price needs to recover soon if the uptrend is to reassert, as it did in April and then early August. A return above $50 would be a good level from where to enter longs as it would imply an attempt to reassert was underway.



Other Developed Indices


Protests in Hong Kong (EWH) have dragged its ETF down sharply the past few weeks. Uptrend support off the 2011 low is being tested and conditions are entering oversold. A bounce back could occur soon, therefore fresh shorts are not recommended.



Emerging Indices


The Brazil Index (EWZ) is reasserting its long-term price and relative downtrends. Weakness over the past two sessions has caused the price to breakdown through a rising trendline off the February low. A test of that low at $38 is possible over the medium-term.



The China 25 Index (FXI) has failed at the top of a three year range. Potential for a retreat back down towards the floor around $32.50. The relative downtrend against the S&P 500 is strongly down and we would avoid longs.



The Emerging Market (EEM) fund shows a similar picture to the FXI as China is a large constituent of the ETF. The price could deteriorate down towards $35, the bottom of a two year range. The relative chart has been falling for the past three years.





The Brazilian Real (BZF) is likely reasserting its long-term downtrend following the bounce over the first six months of the year. The relative trend, versus the U.S. equity market, is also resuming south.

With the price set to return towards the low from 2013 at $16.33, we shall enter a short here. The stoploss will be at $19.





The US 20+ years (TLT) fund maintains its 2014 price uptrend. Support is being provided by the 100-day exponential moving average and conditions are not overbought. The MACD is only just rising through neutral.



ETF Trading (Long/Short) Longs

Date Stock Code Type Open Price Current Price % P&L Stop
29 Jan 2014 iShares S&P National Municipal Bond Fund MUB Long 106.11 109.67 +3.36% 107.25
6 Aug 2014 SPDR Consumer Staples XLP Long 43.79 45.11 +3.01% 42
6 Aug 2014 iShares Germany Index EWG Long 28.35 27.7 -2.29% 25
6 Aug 2014 iShares United Kingdom Index EWU Long 20.165 19.38 -3.89% 18.50
19 Aug 2014 SPDR Sector Trst Health Care XLV Long 62.85 63.91 +1.69% 60
16 Sep 2014 DJ US Pharmaceuticals Index Fund IHE Long 140.31 140.35 +0.03% 135
ETF Trading (Long/Short) Shorts
Date Stock Code Type Open Price Current Price % P&L Stop
2 Jul 2014 Agriculture DBA Short 27.47 25.55 +6.99% 28.50
9 Jul 2014 streetTRACKS KBW Bank ETF KBE Short 33.2 31.91 +3.89% 34.25
16 Sep 2014 Emerging Markets Bond EMB Short 113.58 112.85 +0.64% 115.50
23 Sep 2014 ISHR S&P Small Cap 600 Index IJR Short 105.99 104.3 +1.59% 111
23 Sep 2014 iShares Dow Jones US Aerospace & Defense Index Fund ITA Short 107.96 107.58 +0.35% 112
23 Sep 2014 SPDR Oil & Gas Exp & Prod ETF XOP Short 70.1 68.83 +1.81% 74.50
23 Sep 2014 iShares GS Semiconductor Index SOXX Short 87.2 86.85 +0.40% 90.50
23 Sep 2014 iShares Italy Index EWI Short 15.61 15.69 -0.51% 16.75
23 Sep 2014 iShares Canada Index EWC Short 31.46 30.69 +2.45% 33

Model Portfolio Rules
Allocation – The maximum number of trades is limited to 20 (including longs and shorts).
Opening of positions – Positions are opened at the immediate close following the report, using the closing price.  

Closure of positions – The Analyst may close a position to take profits or exit early to prevent a loss if the outlook has changed. Positions will only be closed if there has been prior mention in the newsletter. The closing price will be at the next close following the report.

Stops – Stop levels are given for each model portfolio position.

Note - When positions are stopped/closed out they will not appear as closures immediately but we plan to update the portfolio table with in 24 hours.
Recommend a friend! Tell your friends to mention your name when subscribing to Investors Intelligence, and get a months free access to a service of your choice! For more information, email

Also available online at Unauthorized forwarding, copying or reproduction of this report will be treated as a breach of copyright. To subscribe, visit the website or contact Investors Intelligence on +44 (0)20 7352 4001 or email

This report has been produced and compiled by Investors Intelligence, a division of Stockcube Research Limited which is authorised and regulated by the Financial Conduct Authority. It is distributed by Stockcube and is provided for information purposes only. Under no circumstances is it to be used or considered as an offer to sell, or a solicitation of any offer to buy. While all reasonable care has been taken to ensure that the information contained herein is not untrue or misleading at the time of publication, we make no representation as to its accuracy or completeness and it should not be relied upon as such. From time to time Stockcube and any of its officers or employees may, to the extent permitted by law, have a position or otherwise be interested in any transactions, in any investments (including derivatives) directly or indirectly the subject of this report. Also Stockcube may from time to time perform other services (including acting as adviser or manager) for any company mentioned in this report. The value of securities can go down as well as up, and you may not get back the full amount you originally invested. Derivatives in particular are high risk, high reward investment instruments and an investor may lose some or all of his/her original investment. If you make an investment in securities that are denominated in a currency other than that of GB Pounds you are warned that changes in rates of foreign exchange may have an adverse effect on the value, price or income of the investment. The investments referred to herein may not be suitable investments for all persons accessing these pages. You should carefully consider whether all or any of these are suitable investments for you and if in any doubt consult an independent adviser. This report is prepared solely for the information of clients of Stockcube who are expected to make their own investment decisions without reliance on this report. Neither Stockcube nor any officer of Stockcube accepts any liability whatsoever for any direct and consequential loss arising from use of this report or its contents. This report may not be reproduced, distributed or published by any recipient for any purpose without the prior express consent of Stockcube.

Copyright 2014 by Stockcube Research Ltd.

Subscribe here:

  • Weekly update
  • Model Portfoilios
  • Online charts